Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines

被引：529

作者：

Mohler, James L. ^{[1
]}

Armstrong, Andrew J. ^{[2
]}

Bahnson, Robert R. ^{[3
,4
]}

D'Amico, Anthony Victor ^{[5
]}

Davis, Brian J. ^{[6
]}

Eastham, James A. ^{[7
]}

Enke, Charles A. ^{[8
]}

Farrington, Thomas A. ^{[9
]}

Higano, Celestia S. ^{[10
]}

Horwitz, Eric M. ^{[11
]}

Hurwitz, Michael ^{[12
]}

Kane, Christopher J. ^{[13
]}

Kawachi, Mark H. ^{[1
,14
]}

Kuettel, Michael

Lee, Richard J. ^{[15
]}

Meeks, Joshua J. ^{[16
]}

Penson, David F. ^{[17
]}

Plimack, Elizabeth R. ^{[11
]}

Pow-Sang, Julio M. ^{[18
]}

Raben, David ^{[19
]}

Richey, Sylvia ^{[20
]}

Roach, Mack, III ^{[21
]}

Rosenfeld, Stan ^{[22
]}

Schaeffer, Edward ^{[23
]}

Skolarus, Ted A. ^{[24
]}

Small, Eric J. ^{[21
]}

Sonpavde, Guru ^{[25
]}

Srinivas, Sandy ^{[26
]}

Strope, Seth A. ^{[27
,28
]}

Tward, Jonathan ^{[29
]}

Shead, Dorothy A. ^{[30
]}

Freedman-Cass, Deborah A. ^{[30
]}

机构：

[1] Roswell Park Canc Inst, Buffalo, NY 14263 USA

[2] Duke Canc Inst, Durham, NC USA

[3] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[4] Solove Res Inst, Columbus, OH USA

[5] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[6] Mayo Clin, Ctr Canc, Rochester, MN USA

[7] Mem Sloan Kettering Canc Ctr, New York, NY USA

[8] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[9] PHEN, Phnom Penh, Cambodia

[10] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98109 USA

[11] Fox Chase Canc Ctr, Philadelphia, PA USA

[12] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[13] UC San Diego Moores Canc Ctr, San Diego, CA USA

[14] City Hope Comprehens Canc Ctr, Duarte, CA USA

[15] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[16] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[17] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[18] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[19] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[20] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[21] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[22] Univ Calif San Francisco, Patient Serv Comm Chair, San Francisco, CA 94143 USA

[23] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[24] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[25] Univ Alabama, Birmingham Comprehens Canc Ctr, Tuscaloosa, AL 35487 USA

[26] Stanford Canc Inst, Stanford, CA USA

[27] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[28] Washington Univ, Sch Med, St Louis, MO 63130 USA

[29] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[30] Natl Comprehens Canc Network, Ft Washington, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 01期

关键词：

BEAM RADIATION-THERAPY; MITOXANTRONE PLUS PREDNISONE; CYCLE PROGRESSION SCORE; RADICAL PROSTATECTOMY; GENOMIC CLASSIFIER; PRETREATMENT NOMOGRAM; RISK STRATIFICATION; ACTIVE SURVEILLANCE; PROGNOSTIC VALUE; ANDROGEN-DEPRIVATION;

D O I：

10.6004/jnccn.2016.0004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naive disease.

引用

页码：19 / 30

页数：12

共 63 条

[1] Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment [J].

Abdollah, Firas ;

Karnes, R. Jeffrey ;

Suardi, Nazareno ;

Cozzarini, Cesare ;

Gandaglia, Giorgio ;

Fossati, Nicola ;

Bianchi, Marco ;

Boorjian, Stephen A. ;

Sun, Maxine ;

Karakiewicz, Pierre I. ;

Montorsi, Francesco ;

Briganti, Alberto .

EUROPEAN UROLOGY, 2014, 65 (03) :554-562

[2] Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study [J].

Berthold, Dominik R. ;

Pond, Gregory R. ;

Soban, Freidele ;

de Wit, Ronald ;

Eisenberger, Mario ;

Tannock, Ian F. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :242-245

[3] Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy [J].

Bishoff, Jay T. ;

Freedland, Stephen J. ;

Gerber, Leah ;

Tennstedt, Pierre ;

Reid, Julia ;

Welbourn, William ;

Graefen, Markus ;

Sangale, Zaina ;

Tikishvili, Eliso ;

Park, Jimmy ;

Younus, Adib ;

Gutin, Alexander ;

Lanchbury, Jerry S. ;

Sauter, Guido ;

Brawer, Michael ;

Stone, Steven ;

Schlomm, Thorsten .

JOURNAL OF UROLOGY, 2014, 192 (02) :409-414

[4] Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer [J].

Blume-Jensen, Peter ;

Berman, David M. ;

Rimm, David L. ;

Shipitsin, Michail ;

Putzi, Mathew ;

Nifong, Thomas P. ;

Small, Clayton ;

Choudhury, Sibgat ;

Capela, Teresa ;

Coupal, Louis ;

Ernst, Christina ;

Hurley, Aeron ;

Kaprelyants, Alex ;

Chang, Hua ;

Giladi, Eldar ;

Nardone, Julie ;

Dunyak, James ;

Loda, Massimo ;

Klein, Eric A. ;

Magi-Galluzzi, Cristina ;

Latour, Mathieu ;

Epstein, Jonathan I. ;

Kantoff, Philip ;

Saad, Fred .

CLINICAL CANCER RESEARCH, 2015, 21 (11) :2591-2600

[5] A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer [J].

Briganti, Alberto ;

Chun, Felix K-H. ;

Salonia, Andrea ;

Zanni, Giuseppe ;

Gallina, Andrea ;

Deho, Federico ;

Suardi, Nazareno ;

Da Pozzo, Luigi Filippo ;

Valiquette, Luc ;

Rigatti, Patrizio ;

Montorsi, Francesco ;

Karakiewicz, PierreI .

EUROPEAN UROLOGY, 2007, 51 (01) :112-120

[6] Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort [J].

Cooperberg, Matthew R. ;

Davicioni, Elai ;

Crisan, Anamaria ;

Jenkins, Robert B. ;

Ghadessi, Mercedeh ;

Karnes, R. Jeffrey .

EUROPEAN UROLOGY, 2015, 67 (02) :326-333

[7] Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort [J].

Cooperberg, Matthew R. ;

Simko, Jeffry P. ;

Cowan, Janet E. ;

Reid, Julia E. ;

Djalilvand, Azita ;

Bhatnagar, Satish ;

Gutin, Alexander ;

Lanchbury, Jerry S. ;

Swanson, Gregory P. ;

Stone, Steven ;

Carroll, Peter R. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) :1428-1434

[8] A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer [J].

Cullen, Jennifer ;

Rosner, Inger L. ;

Brand, Timothy C. ;

Zhang, Nan ;

Tsiatis, Athanasios C. ;

Moncur, Joel ;

Ali, Amina ;

Chen, Yongmei ;

Knezevic, Dejan ;

Maddala, Tara ;

Lawrence, H. Jeffrey ;

Febbo, Phillip G. ;

Srivastava, Shiv ;

Sesterhenn, Isabell A. ;

McLeod, David G. .

EUROPEAN UROLOGY, 2015, 68 (01) :123-131

[9] Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort [J].

Cuzick, J. ;

Stone, S. ;

Fisher, G. ;

Yang, Z. H. ;

North, B. V. ;

Berney, D. M. ;

Beltran, L. ;

Greenberg, D. ;

Moller, H. ;

Reid, J. E. ;

Gutin, A. ;

Lanchbury, J. S. ;

Brawer, M. ;

Scardino, P. .

BRITISH JOURNAL OF CANCER, 2015, 113 (03) :382-389

[10] Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer [J].

Cuzick, J. ;

Yang, Z. H. ;

Fisher, G. ;

Tikishvili, E. ;

Stone, S. ;

Lanchbury, J. S. ;

Camacho, N. ;

Merson, S. ;

Brewer, D. ;

Cooper, C. S. ;

Clark, J. ;

Berney, D. M. ;

Moller, H. ;

Scardino, P. ;

Sangale, Z. .

BRITISH JOURNAL OF CANCER, 2013, 108 (12) :2582-2589

← 1 2 3 4 5 6 7 →